In contrast to 100% of reported CNS tumors with BCOR ITD, tumors with BCOR fusion do not all exhibit an overexpression of the BCOR protein by immunohistochemistry (present in 43% of reported cases) [17, 19, 21]. This evidence concerns the gene BCOR and central nervous system neoplasm.